Cardiovascular Device Company Exceeds Patient Enrollment Goals
Learn how a medical device company scaled its post-market trial for cardiovascular grafts and patches to meet new EU MDR requirements during the global pandemic.
With a flexible approach, IQVIA MedTech used its cardiovascular post-market clinical experience to exceed patient enrollment goals six months ahead of schedule.
Discover how IQVIA MedTech:
- Activated 31 sites across seven countries
- Helped the sponsor maintain EU MDR compliance on five legacy medical devices
- Leveraged its therapeutic area expertise to enroll and retain over 1,600 patients for a post-market cardiovascular trial that required long-term follow-up
Ready to discuss how IQVIA MedTech can help accelerate your cardiovascular medical device innovation? Fill out this form to speak to an expert.
